AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mergo, P. J.
Right arrow Articles by Ros, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mergo, P. J.
Right arrow Articles by Ros, P. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 166, 379-384, Copyright © 1996 by American Roentgen Ray Society


ARTICLES

Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions

PJ Mergo, T Helmberger, AI Nicolas and PR Ros
Department of Radiology, University of Florida College of Medicine, Gainesville 32610, USA.

OBJECTIVE: We performed this study to evaluate the incidence and significance of ring enhancement after i.v. administration of an ultrasmall superparamagnetic iron oxide (USPIO) particle (Code 7227), a reticuloendothelial contrast agent with potential use as a blood-pool agent, for characterizing focal hepatic lesions. SUBJECTS AND METHODS: Conventional T1-weighed imaging, fat-suppressed T1-weighted imaging, conventional T2-weighted imaging, and fast T2-weighted imaging of the liver were obtained in 27 patients with 43 liver lesions before and after i.v. administration of a USPIO preparation. All lesions were larger than 1 cm; 29 were malignant and 14 were benign. Diagnosis was confirmed in all cases, either pathologically (19 patients) or by follow-up examination (eight patients). Two readers independently evaluated each pulse sequence for the presence of ring enhancement of hepatic lesions. RESULTS: Ring enhancement was noted only on T1- weighted images, with no ring enhancement evident on T2-weighted images. Twenty of 43 (47%) lesions showed ring enhancement, including 18 of 29 (62%) malignant lesions and two of 14 (14%) benign lesions (p < .011); Wilcoxon signed rank test). Fat-suppressed T1-weighted imaging showed ring enhancement better than or equal to conventional T1- weighted imaging in all cases, with ring enhancement of 15 of 18 (83%) malignant lesions and two of two benign lesions better demonstrated on fat-suppressed T1-weighted imaging sequences (p < or = .025). CONCLUSION: Ring enhancement after i.v. administration of Code 7227 is a frequent finding seen more often with malignant than benign lesions, potentially identifying a new MR imaging feature for the characterization of liver lesions. The identification of ring enhancement on T1-weighted images attests to the significant blood-pool effects of USPIO particles.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
M. Matsuo, M. Kanematsu, K. Itoh, T. Murakami, Y. Maetani, H. Kondo, S. Goshima, N. Kako, H. Hoshi, J. Konishi, et al.
Detection of Malignant Hepatic Tumors with Ferumoxides-Enhanced MRI: Comparison of Five Gradient-Recalled Echo Sequences with Different TEs
Am. J. Roentgenol., January 1, 2004; 182(1): 235 - 242.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. Reimer, N. Jähnke, M. Fiebich, W. Schima, F. Deckers, C. Marx, N. Holzknecht, and S. Saini
Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-enhanced MR Imaging, and Spiral CT-ROC Analysis
Radiology, October 1, 2000; 217(1): 152 - 158.
[Abstract] [Full Text]


Home page
RadiologyHome page
J. B. Kruskal, P. Thomas, I. Nasser, O. Cay, and R. A. Kane
Hepatic Colon Cancer Metastases in Mice: Dynamic in Vivo Correlation with Hypoechoic Rims Visible at US
Radiology, June 1, 2000; 215(3): 852 - 857.
[Abstract] [Full Text]


Home page
Am. J. Roentgenol.Home page
G. T. Sica, H. Ji, and P. R. Ros
CT and MR Imaging of Hepatic Metastases
Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698.
[Full Text] [PDF]


Home page
RadiologyHome page
K. H. Ahlström, L. O. Johansson, J. B. Rodenburg, A. S. Ragnarsson, P. Åkeson, and A. Börseth
Pulmonary MR Angiography with Ultrasmall Superparamagnetic Iron Oxide Particles as a Blood Pool Agent and a Navigator Echo for Respiratory Gating: Pilot Study
Radiology, June 1, 1999; 211(3): 865 - 869.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Roentgen Ray Society.